Literature DB >> 16672925

Finding function in novel targets: C. elegans as a model organism.

Titus Kaletta1, Michael O Hengartner.   

Abstract

Despite its apparent simplicity, the nematode worm Caenorhabditis elegans has developed into an important model for biomedical research, particularly in the functional characterization of novel drug targets that have been identified using genomics technologies. The cellular complexity and the conservation of disease pathways between C. elegans and higher organisms, together with the simplicity and cost-effectiveness of cultivation, make for an effective in vivo model that is amenable to whole-organism high-throughput compound screens and large-scale target validation. This review describes how C. elegans models can be used to advance our understanding of the molecular mechanisms of drug action and disease pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16672925     DOI: 10.1038/nrd2031

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


  292 in total

1.  Microfluidic chamber arrays for whole-organism behavior-based chemical screening.

Authors:  Kwanghun Chung; Mei Zhan; Jagan Srinivasan; Paul W Sternberg; Emily Gong; Frank C Schroeder; Hang Lu
Journal:  Lab Chip       Date:  2011-09-20       Impact factor: 6.799

2.  Evaluation of the toxicity of 2-aminoimidazole antibiofilm agents using both cellular and model organism systems.

Authors:  Sean D Stowe; Ashley T Tucker; Richele Thompson; Amanda Piper; Justin J Richards; Steven A Rogers; Laura D Mathies; Christian Melander; John Cavanagh
Journal:  Drug Chem Toxicol       Date:  2012-01-31       Impact factor: 3.356

3.  Chemosensory cue conditioning with stimulants in a Caenorhabditis elegans animal model of addiction.

Authors:  Heather N Musselman; Bethany Neal-Beliveau; Richard Nass; Eric A Engleman
Journal:  Behav Neurosci       Date:  2012-06       Impact factor: 1.912

4.  Antipsychotic drugs activate the C. elegans akt pathway via the DAF-2 insulin/IGF-1 receptor.

Authors:  Kathrine R Weeks; Donard S Dwyer; Eric J Aamodt
Journal:  ACS Chem Neurosci       Date:  2010-03-25       Impact factor: 4.418

5.  Fluoxetine protects against amyloid-beta toxicity, in part via daf-16 mediated cell signaling pathway, in Caenorhabditis elegans.

Authors:  Roongpetch Keowkase; Marwa Aboukhatwa; Yuan Luo
Journal:  Neuropharmacology       Date:  2010-04-24       Impact factor: 5.250

Review 6.  In vivo RNAi: today and tomorrow.

Authors:  Norbert Perrimon; Jian-Quan Ni; Lizabeth Perkins
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-06-09       Impact factor: 10.005

7.  Whole-Genome Analysis of Bacillus thuringiensis Revealing Partial Genes as a Source of Novel Cry Toxins.

Authors:  Muhammad Sajid; Ce Geng; Miaomiao Li; Yueying Wang; Hualin Liu; Jinshui Zheng; Donghai Peng; Ming Sun
Journal:  Appl Environ Microbiol       Date:  2018-07-02       Impact factor: 4.792

Review 8.  How early media exposure may affect cognitive function: A review of results from observations in humans and experiments in mice.

Authors:  Dimitri A Christakis; Julian S Benedikt Ramirez; Susan M Ferguson; Shilpa Ravinder; Jan-Marino Ramirez
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-02       Impact factor: 11.205

Review 9.  Modular assembly of primary metabolic building blocks: a chemical language in C. elegans.

Authors:  Frank C Schroeder
Journal:  Chem Biol       Date:  2014-12-04

10.  Multimodal imaging and high-throughput image-processing for drug screening on living organisms on-chip.

Authors:  Daniel Migliozzi; Matteo Cornaglia; Laurent Mouchiroud; Virginie Uhlmann; Michael A Unser; Johan Auwerx; Martin A M Gijs
Journal:  J Biomed Opt       Date:  2018-11       Impact factor: 3.170

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.